IQVIA HOLDINGS INC. IQV
NYSE · XNYS · stock · Services-Commercial Physical & Biological Research
Chart by TradingView
5/9
Piotroski F — financial health
1.13
Altman Z″ — distress risk · grey
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $16.3B | $1.4B | — | — | $6.5B |
| 2024 | $15.4B | $1.4B | — | — | $6.1B |
| 2023 | $15.0B | $1.4B | — | — | $6.1B |
| 2022 | $14.4B | $1.1B | — | — | $5.8B |
| 2021 | $13.9B | $966.0M | — | — | $6.0B |
| 2020 | $11.4B | $279.0M | — | — | $6.3B |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| LEONARD JOHN M | director | 2026-04-23 | Grant | 1,571 | — |
| GOGGINS COLLEEN A | director | 2026-04-23 | Grant | 1,571 | — |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 1.13 (grey)
- Working capital / assets -0.07
- Retained earnings / assets 0.248
- EBIT / assets 0.073
- Equity / liabilities 0.279
Source: SEC EDGAR filings · CIK 0001478242 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.